New study aims to cut arthritis flares by tailoring drug tapering
NCT ID NCT06528431
First seen Jan 04, 2026 · Last updated Jun 12, 2026 · Updated 27 times
Summary
This study tests a personalized approach to slowly reduce the dose of the biologic drug adalimumab in people with rheumatoid arthritis who are in remission. The goal is to find the best blood level of the drug before each dose reduction to lower the risk of disease flares. 180 adults with stable RA will be followed to see if this tailored tapering strategy works better than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ap-Hp Pitie Salpetriere
RECRUITINGParis, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chd Vendee
RECRUITINGLa Roche-sur-Yon, 85925, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chru Tours
NOT_YET_RECRUITINGTours, 37170, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Montpellier
RECRUITINGMontpellier, 34295, France
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Reims
NOT_YET_RECRUITINGReims, 51100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Saint Etienne
RECRUITINGSaint-Etienne, 42055, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hopital Philibert
RECRUITINGLomme, 59160, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Infirmerie Protestante
RECRUITINGCaluire-et-Cuire, 69300, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.